Skip to main content
Top
Published in: BMC Nephrology 1/2012

Open Access 01-12-2012 | Research article

Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?

Authors: Hugo Hyung Bok Yoo, Luis Cuadrado Martin, Ana Claudia Kochi, Lidiane Silva Rodrigues-Telini, Pasqual Barretti, Jacqueline Teixeira Caramori, Beatriz Bojikian Matsubara, Silméia Garcia Zannati-Bazan, Roberto Jorge da Silva Franco, Thais Thomaz Queluz

Published in: BMC Nephrology | Issue 1/2012

Login to get access

Abstract

Background

The pathogenesis of pulmonary hypertension (PH) in hemodialysis is still unclear. The aim of this study was to identify the risk factors associated with the presence of PH in chronic hemodialysis patients and to verify whether these factors might explain the highest mortality among them.

Methods

We conducted a retrospective study of hemodialysis patients who started treatment from August 2001 to October 2007 and were followed up until April 2011 in a Brazilian referral medical school. According to the results of echocardiography examination, patients were allocated in two groups: those with PH and those without PH. Clinical parameters, site and type of vascular access, bioimpedance, and laboratorial findings were compared between the groups and a logistic regression model was elaborated. Actuarial survival curves were constructed and hazard risk to death was evaluated by Cox regression analysis.

Results

PH > 35 mmHg was found in 23 (30.6%) of the 75 patients studied. The groups differed in extracellular water, ventricular thickness, left atrium diameter, and ventricular filling. In a univariate analysis, extracellular water was associated with PH (relative risk = 1.194; 95% CI of 1.006 – 1.416; p = 0.042); nevertheless, in a multiple model, only left atrium enlargement was independently associated with PH (relative risk =1.172; 95% CI of 1.010 – 1.359; p = 0.036). PH (hazard risk = 3.008; 95% CI of 1.285 – 7.043; p = 0.011) and age (hazard risk of 1.034 per year of age; 95% CI of 1.000 – 7.068; p = 0.047) were significantly associated with mortality in a multiple Cox regression analysis. However, when albumin was taken in account the only statistically significant association was between albumin level and mortality (hazard risk = 0.342 per g/dL; 95% CI of 0.119 – 0.984; p = 0.047) while the presence of PH lost its statistical significance (p = 0.184). Mortality was higher in patients with PH (47.8% vs 25%) who also had a statistically worse survival after the sixth year of follow up.

Conclusions

PH in hemodialysis patients is associated with parameters of volume overload that sheds light on its pathophysiology. Mortality is higher in hemodialysis patients with PH and the low albumin level can explain this association.
Appendix
Available only for authorised users
Literature
1.
go back to reference Runo JR, Loyd JE: Primary pulmonary hypertension. Lancet. 2003, 361: 1533-1544. 10.1016/S0140-6736(03)13167-4.CrossRefPubMed Runo JR, Loyd JE: Primary pulmonary hypertension. Lancet. 2003, 361: 1533-1544. 10.1016/S0140-6736(03)13167-4.CrossRefPubMed
2.
go back to reference Rich S: Primary pulmonary hypertension. Prog Cardiovasc Dis. 1998, 31: 205-238.CrossRef Rich S: Primary pulmonary hypertension. Prog Cardiovasc Dis. 1998, 31: 205-238.CrossRef
3.
go back to reference Yigla M, Dabbah S, Azzam ZS, Rubin AH, Reisner SA: Background disease in 671 patients with moderate to severe pulmonary hypertension. Isr Med Assoc J. 2000, 2: 684-689.PubMed Yigla M, Dabbah S, Azzam ZS, Rubin AH, Reisner SA: Background disease in 671 patients with moderate to severe pulmonary hypertension. Isr Med Assoc J. 2000, 2: 684-689.PubMed
4.
go back to reference Yu TM, Chen YH, Hsu JY, Sun CS, Chuang YW, Chen CH, Wu MJ, Cheng CH, Shu KH: Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis. Nephrol Dial Transplant. 2009, 24: 1946-1951. 10.1093/ndt/gfn751.CrossRefPubMed Yu TM, Chen YH, Hsu JY, Sun CS, Chuang YW, Chen CH, Wu MJ, Cheng CH, Shu KH: Systemic inflammation is associated with pulmonary hypertension in patients undergoing haemodialysis. Nephrol Dial Transplant. 2009, 24: 1946-1951. 10.1093/ndt/gfn751.CrossRefPubMed
5.
go back to reference Ifudu O: Care of patients undergoing hemodialysis. N Engl J Med. 1998, 339: 1054-1062. 10.1056/NEJM199810083391507.CrossRefPubMed Ifudu O: Care of patients undergoing hemodialysis. N Engl J Med. 1998, 339: 1054-1062. 10.1056/NEJM199810083391507.CrossRefPubMed
6.
go back to reference Bozbas SS, Akcay S, Altin C, Bozbas H, Karacaglar E, Kanyilmaz S, Sayin B, Muderrisoglu H, Haberal M: Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant Proc. 2009, 41: 2753-2756. 10.1016/j.transproceed.2009.07.049.CrossRefPubMed Bozbas SS, Akcay S, Altin C, Bozbas H, Karacaglar E, Kanyilmaz S, Sayin B, Muderrisoglu H, Haberal M: Pulmonary hypertension in patients with end-stage renal disease undergoing renal transplantation. Transplant Proc. 2009, 41: 2753-2756. 10.1016/j.transproceed.2009.07.049.CrossRefPubMed
7.
go back to reference Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, Reisner SA: Pulmonary hypertension in patients with end-stage renal disease. Chest. 2003, 123: 1577-1582. 10.1378/chest.123.5.1577.CrossRefPubMed Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, Reisner SA: Pulmonary hypertension in patients with end-stage renal disease. Chest. 2003, 123: 1577-1582. 10.1378/chest.123.5.1577.CrossRefPubMed
8.
go back to reference Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA, Lewin M, Nakhoul F: Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009, 75: 969-975. 10.1038/ki.2009.10.CrossRefPubMed Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA, Lewin M, Nakhoul F: Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int. 2009, 75: 969-975. 10.1038/ki.2009.10.CrossRefPubMed
9.
go back to reference Agarwal R: Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant. 2012, Epub ahead of print Agarwal R: Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Nephrol Dial Transplant. 2012, Epub ahead of print
10.
go back to reference Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA: Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American society of Echocardiography. J Am Soc Echocardiogr. 2002, 15: 167-184. 10.1067/mje.2002.120202.CrossRefPubMed Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA: Recommendations for quantification of Doppler echocardiography: a report from the Doppler quantification task force of the nomenclature and standards committee of the American society of Echocardiography. J Am Soc Echocardiogr. 2002, 15: 167-184. 10.1067/mje.2002.120202.CrossRefPubMed
11.
go back to reference Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group American Society of Echocardiography's Guidelines and Standards Committee European Association of Echocardiography: Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016/j.echo.2005.10.005.CrossRefPubMed Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group American Society of Echocardiography's Guidelines and Standards Committee European Association of Echocardiography: Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016/j.echo.2005.10.005.CrossRefPubMed
12.
go back to reference Kitabatake A, Inoue M, Asao M, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Hori M, Abe H: Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation. 1983, 68: 302-309. 10.1161/01.CIR.68.2.302.CrossRefPubMed Kitabatake A, Inoue M, Asao M, Masuyama T, Tanouchi J, Morita T, Mishima M, Uematsu M, Shimazu T, Hori M, Abe H: Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation. 1983, 68: 302-309. 10.1161/01.CIR.68.2.302.CrossRefPubMed
14.
go back to reference Kushner RF, Schoeller DA: Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr. 1986, 44: 417-424.PubMed Kushner RF, Schoeller DA: Estimation of total body water by bioelectrical impedance analysis. Am J Clin Nutr. 1986, 44: 417-424.PubMed
15.
go back to reference Cohn SH, Vaswani AN, Yasumura S, Yuen K, Ellis KJ: Assessment of cellular mass and lean body mass by noninvasive nuclear techniques. J Lab Clin Med. 1985, 105: 305-311.PubMed Cohn SH, Vaswani AN, Yasumura S, Yuen K, Ellis KJ: Assessment of cellular mass and lean body mass by noninvasive nuclear techniques. J Lab Clin Med. 1985, 105: 305-311.PubMed
16.
go back to reference Greenwod M: The errors of sampling of the survivorship tables. Appendix 1 in Reports on public health and statistical subjects, No 33. 1926, London: His Majesty’s Stationery Office Greenwod M: The errors of sampling of the survivorship tables. Appendix 1 in Reports on public health and statistical subjects, No 33. 1926, London: His Majesty’s Stationery Office
17.
go back to reference Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, Dinc G: Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007, 74: 503-510. 10.1159/000102953.CrossRefPubMed Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, Dinc G: Pulmonary hypertension in patients with chronic renal failure. Respiration. 2007, 74: 503-510. 10.1159/000102953.CrossRefPubMed
18.
go back to reference Tarrass F, Benjelloun M, Hachim K, Benghanem MG, Ramdani B: Pulmonary hypertension in patients with end-stage renal disease. Indian J Nephrol. 2005, 15: 223-226. Tarrass F, Benjelloun M, Hachim K, Benghanem MG, Ramdani B: Pulmonary hypertension in patients with end-stage renal disease. Indian J Nephrol. 2005, 15: 223-226.
19.
go back to reference Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z: The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant. 2005, 20: 1686-1692. 10.1093/ndt/gfh840.CrossRefPubMed Nakhoul F, Yigla M, Gilman R, Reisner SA, Abassi Z: The pathogenesis of pulmonary hypertension in haemodialysis patients via arterio-venous access. Nephrol Dial Transplant. 2005, 20: 1686-1692. 10.1093/ndt/gfh840.CrossRefPubMed
20.
go back to reference Amin M, Fawzy A, Hamid MA, Elhendy A: Pulmonary hypertension in patients with chronic renal failure. Role of parathyroid hormone and pulmonary artery calcifications. Chest. 2003, 124: 2093-2097. 10.1378/chest.124.6.2093.CrossRefPubMed Amin M, Fawzy A, Hamid MA, Elhendy A: Pulmonary hypertension in patients with chronic renal failure. Role of parathyroid hormone and pulmonary artery calcifications. Chest. 2003, 124: 2093-2097. 10.1378/chest.124.6.2093.CrossRefPubMed
21.
go back to reference Abdelwhab S, Elshinnawy S: Pulmonary hypertension in chronic renal failure patients. Am J Nephrol. 2008, 28: 990-997. 10.1159/000146076.CrossRefPubMed Abdelwhab S, Elshinnawy S: Pulmonary hypertension in chronic renal failure patients. Am J Nephrol. 2008, 28: 990-997. 10.1159/000146076.CrossRefPubMed
22.
go back to reference Khush KK, Tasissa G, Javed Butler J, McGlothlin D, De Marco T, for the ESCAPE Investigators: Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: Analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J. 2009, 157: 1026-1034. 10.1016/j.ahj.2009.02.022.CrossRefPubMed Khush KK, Tasissa G, Javed Butler J, McGlothlin D, De Marco T, for the ESCAPE Investigators: Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: Analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J. 2009, 157: 1026-1034. 10.1016/j.ahj.2009.02.022.CrossRefPubMed
Metadata
Title
Could albumin level explain the higher mortality in hemodialysis patients with pulmonary hypertension?
Authors
Hugo Hyung Bok Yoo
Luis Cuadrado Martin
Ana Claudia Kochi
Lidiane Silva Rodrigues-Telini
Pasqual Barretti
Jacqueline Teixeira Caramori
Beatriz Bojikian Matsubara
Silméia Garcia Zannati-Bazan
Roberto Jorge da Silva Franco
Thais Thomaz Queluz
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2012
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-13-80

Other articles of this Issue 1/2012

BMC Nephrology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine